Life Healthcare seals deal on cancer-screening tool

Life Healthcare’s subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million.

Membership Required

You must be a member to access this content.

Already a member? Log in here